↓ Skip to main content

Preparation of peptide-loaded dendritic cells for cancer immunotherapy

Overview of attention for article published in Molecular Biotechnology, January 2003
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
10 Mendeley
citeulike
1 CiteULike
Title
Preparation of peptide-loaded dendritic cells for cancer immunotherapy
Published in
Molecular Biotechnology, January 2003
DOI 10.1385/mb:25:1:95
Pubmed ID
Authors

Michael A. Morse, Tim Clay, Kirsten Colling, H. Kim Lyerly

Abstract

Dendritic cell-based vaccines are being evaluated in clinical trials to determine their ability to activate clinically relevant tumor antigen-specific immune responses. Although some groups isolate dendritic cells from peripheral blood, most have found it more efficient to generate large numbers from peripheral blood progenitors, particularly plastic adherent or CD14+ monocytes, in media supplemented with GM-CSF and IL-4. These DC may then be matured, if desired, and loaded with antigen, such as tumor-associated peptides, prior to administration. We describe the scheme that we are currently using to generate peptide-loaded dendritic cells for our clinical trials of cancer immunotherapy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 10%
Unknown 9 90%

Demographic breakdown

Readers by professional status Count As %
Other 2 20%
Student > Ph. D. Student 2 20%
Student > Master 2 20%
Researcher 2 20%
Student > Postgraduate 1 10%
Other 0 0%
Unknown 1 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 40%
Medicine and Dentistry 2 20%
Immunology and Microbiology 2 20%
Computer Science 1 10%
Unknown 1 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2013.
All research outputs
#7,473,822
of 22,849,304 outputs
Outputs from Molecular Biotechnology
#275
of 961 outputs
Outputs of similar age
#31,555
of 129,303 outputs
Outputs of similar age from Molecular Biotechnology
#11
of 23 outputs
Altmetric has tracked 22,849,304 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 961 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 129,303 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.